3652 results for «271»
3652 results
Gulf WIN - Opportunities and challenges
15 Dec 2022 – From GulfPCR-GIM 2022
Women have the floor in this special GulfPCR-GIM 2022 session: hear from members of the Gulf WIN (Women In Intervention) to better understand the status of women interventionists in the region, explore the challenges they face, and note the differences that exist with other women cardiologists...
Optimal management of a patient with calcified lesions - Session with LIVE case
15 Dec 2022 – From GulfPCR-GIM 2022
Watch the case of an 87-year-old male patient with DM, HTN, and hyperlipidemia, who suffered ACS six weeks ago, whose culprit lesions were treated in the RCA and LCX, and who was incidentally readmitted for LAD PCI, and find out how he was treated LIVE.
Essential drugs that every interventionalist needs to know
15 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, learn about the role of PCSK9 inhibitors in ACS and post-PCI patients, the role of SGLT2 receptor blockers and GLP RAs, and the role of P2Y12 inhibitors as unique post-PCI antiplatelet agents.
Severe mitral and tricuspid regurgitation
15 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session aims to illustrate the role of mitral TEER in patients with significant MR and cardiogenic shock, to demonstrate the importance of early detection, but also to show that earlier referral and treatment of patients with significant TR is essential to prevent patients...
Imaging for tricuspid valve interventions
17 Feb 2023 – From PCR Tokyo Valves 2023
After reviewing the anatomy of the tricuspid valve, learn, in this PCR Tokyo Valves 2023 session on this specific valve, how to evaluate it with trans-oesophageal echocardiography, how to classify TR, what the pitfalls are, and tips and tricks for intra-procedural imaging.
Imaging for aortic valve interventions
17 Feb 2023 – From PCR Tokyo Valves 2023
In this session, review the anatomy of the aortic valve system, learn how to assess low-flow, low-gradient severe AS, identify the pitfalls to avoid when assessing paravalvular leakage after TAVI, and find out more about how to detect valve thrombosis and degeneration, among others!
Imaging for mitral valve interventions
17 Feb 2023 – From PCR Tokyo Valves 2023
Watch this PCR Tokyo Valves 2023 session to review the anatomy of the mitral valve, learn how to assess it with a trans-oesophageal echocardiography, find out how to grade MR and avoid its pitfalls, and get tips and tricks for successful intraprocedural TEE.
TAVI with advanced imaging techniques - LIVE case
18 Feb 2023 – From PCR Tokyo Valves 2023
A 93-year-old female, with chronic kidney disease (GFR:34), diabetes, first degree AV block, present a symptomatic severe calcified aortic stenosis. Watch the operators as they implant an Evolut pro 26mm, guided by ICE in order to check the position of the distal part of the valve with...
AIMI-HF trial - Ischemia and viability imaging in heart failure: The alternative imaging modalities in ischemic heart failure trial
05 Mar 2023
Nicola Ryan provides her take on this clinical trial presented by Lisa Mielniczuk at the American College of Cardiology Scientific Session (ACC.23/WCC) – note this analysis is based upon the presented slides alone.
Author
Does metallic stent ablation by rotational atherectomy influence on the coronary microcirculation?
09 Jul 2019
An 80-year-old man underwent percutaneous coronary intervention with a bare-metal stent for severe stenosis at proximal left anterior descending coronary artery 13 years ago. In-stent restenosis was treated by a drug-eluting stent 1 year later...
TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
31 Aug 2024
Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.
Simultaneous publication in European Heart Journal, ehae578
Author
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
